CLASS II Drug recall · Reported 14 Jun 2017 · FDA Enforcement Report
Option 2, Levonorgestrel Tablet, 1.5 mg, Emergency Contraceptive recalled
L. Perrigo is recalling Option 2, Levonorgestrel Tablet, 1.5 mg, Emergency Contraceptive per, distributed nationwide in the US. The recall was initiated on 1 Jun 2017 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0887-2017
- FDA event ID
- 77397
- Recalling firm
- L. Perrigo, Allegan, MI
- Brand
- Option 2
- Manufacturer
- L. Perrigo Company
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 1 Jun 2017
- FDA classified
- 6 Jun 2017
- Reported
- 14 Jun 2017
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Hormones & Birth Control
Timeline
| 1 Jun 2017 | Recall initiated by company | |
| 6 Jun 2017 | Classified by FDA | +5 days |
| 14 Jun 2017 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Defective Container: Carton is missing the tablet blister strip and tablet.
Product as listed by the FDA
Option 2, Levonorgestrel Tablet, 1.5 mg, Emergency Contraceptive, 1 Tablet per box, Distributed By Perrigo, Allegan, MI 49010. NDC 0113-2003-12
Where it was distributed
Nationwide in the US and Canada
Questions about this recall
Why was it recalled?
Defective Container: Carton is missing the tablet blister strip and tablet.
Which lots are affected?
Lot #: 6LV1114, 6LV1115, 6LV1116, 6MV0976, 6MV0977, Exp.04/18; 7AV1173, 7AV1175, 7AV1176, Exp.07/18.
Where was it sold?
Nationwide in the US and Canada
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from L. Perrigo
All 28| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | aller-ease, Fexofenadine Hydrochloride Tablets, 180 mg recalledExchange Select Aller Ease | L. Perrigo | Potency & Assay | Nationwide |
| Drug | CLASS II | Allergy Aller-fex, Fexofenadine Hydrochloride Tablets, 180 mg recalledKirkland Signature Aller Fex | L. Perrigo | Potency & Assay | Nationwide |
| Drug | CLASS II | Non-Drowsy Allergy Relief, Fexofenadine Hydrochloride recalledBerkley Jensen Allergy Relief | L. Perrigo | Potency & Assay | Nationwide |
| Drug | CLASS II | Allergy, Fexofenadine Hydrochloride Tablets, 180 mg recalledBasic Care Allergy | L. Perrigo | Potency & Assay | Nationwide |
| Drug | CLASS II | Picnic, Fexofenadine Hydrochloride Tablets, 180 mg, Antihistamine recalled | L. Perrigo | Potency & Assay | Nationwide |
Other Levonorgestrel recalls
All 6| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Levonorgestrel and Ethinyl Estradiol Tablets recalled | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg recalled | Mylan Pharmaceuticals | Other | Nationwide |
| Drug | CLASS III | Altavera Levonorgestrel and Ethinyl Estradiol Tablets recalledAltavera | Xiromed | Labeling Errors | Nationwide |
| Drug | CLASS III | Lessina(R) (Levonorgestrel and ethinyl estradiol tablets recalledLessina | Teva Pharmaceuticals USA | Benzene | Nationwide |
| Drug | CLASS III | Portia (levonorgestrel and ethinyl estradiol) Tablets recalledPortia | Teva Pharmaceuticals USA | Potency & Assay | Nationwide |